TAF13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.783390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.558400E-01
Normal-vs-Stage2
1.773570E-01
Normal-vs-Stage3
5.373400E-01
Normal-vs-Stage4
1.659640E-02
Stage1-vs-Stage2
9.604600E-01
Stage1-vs-Stage3
3.965800E-01
Stage1-vs-Stage4
1.136950E-01
Stage2-vs-Stage3
3.120800E-01
Stage2-vs-Stage4
4.731600E-02
Stage3-vs-Stage4
1.693890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.776430E-01
Normal-vs-AfricanAmerican
1.209420E-01
Normal-vs-Asian
4.135600E-01
Caucasian-vs-AfricanAmerican
1.623050E-01
Caucasian-vs-Asian
6.879400E-01
AfricanAmerican-vs-Asian
2.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.127000E-01
Normal-vs-Female
1.467200E-01
Male-vs-Female
3.176200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.874400E-01
Normal-vs-Age(41-60Yrs)
5.098400E-02
Normal-vs-Age(61-80Yrs)
2.549400E-01
Normal-vs-Age(81-100Yrs)
5.451800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.833200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.298600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.989800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.917590E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.961500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.593400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.489000E-01
Normal-vs-Daily Drinker
4.986000E-01
Normal-vs-Weekly Drinker
2.716600E-01
Normal-vs-Occasional Drinker
4.346000E-02
Normal-vs-Social Drinker
1.942810E-01
Non Drinker-vs-Daily Drinker
5.445200E-01
Non Drinker-vs-Weekly Drinker
3.387400E-01
Non Drinker-vs-Occasional Drinker
3.040400E-02
Non Drinker-vs-Social Drinker
2.017200E-01
Daily Drinker-vs-Weekly Drinker
1.814840E-01
Daily Drinker-vs-Occasional Drinker
9.436000E-03
Daily Drinker-vs-Social Drinker
9.691600E-02
Weekly Drinker-vs-Occasional Drinker
4.571800E-01
Weekly Drinker-vs-Social Drinker
8.418400E-01
Occasional Drinker-vs-Social Drinker
5.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.579200E-01
Normal-vs-Grade 2
9.451600E-01
Normal-vs-Grade 3
9.025800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.056570E-01
Grade 1-vs-Grade 3
4.492000E-01
Grade 1-vs-Grade 4
8.579200E-01
Grade 2-vs-Grade 3
3.193400E-01
Grade 2-vs-Grade 4
9.451600E-01
Grade 3-vs-Grade 4
9.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.610200E-01
Normal-vs-NonDiabetic
2.393200E-01
Diabetic-vs-NonDiabetic
9.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.672390E-01
Normal-vs-NoPancreatitis
2.186000E-01
Pancreatitis-vs-NoPancreatitis
9.274800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.543400E-01
Normal-vs-N1
1.564020E-01
N0-vs-N1
5.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.966000E-01
Normal-vs-TP53-NonMutant
3.848600E-01
TP53-Mutant-vs-TP53-NonMutant
5.857600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
